Abstract
Background: Cardiorespiratory limitation is a common hallmark of cardiovascular disease which is a key component of pharmacological and exercise treatments. More recently, inspiratory muscle training (IMT) is becoming an effective complementary treatment with positive effects on muscle strength and exercise capacity. We assessed the effectiveness of IMT on the cardiovascular system through autonomic function modulation via heart rate variability and arterial blood pressure.
Methods: Randomized controlled trials (RCTs) were identified from searches of The Cochrane Library, MEDLINE and EMBASE to November 2018. Citations, conference proceedings and previous reviews were included without population restriction, comparing IMT intervention to no treatment, placebo or active control.
Results: We identified 10 RCTs involving 267 subjects (mean age range 51–71 years). IMT programs targeted maximum inspiratory pressure (MIP) and cardiovascular outcomes, using low (n=6) and moderate to high intensity (n=4) protocols, but the protocols varied considerably (duration: 1–12 weeks, frequency: 3–14 times/week, time: 10–30 mins). An overall increase of the MIP (cmH2O) was observed (−27.57 95% CI −18.48, −37.45, I2=64%), according to weighted mean difference (95%CI), and was accompanied by a reduction of the low to high frequency ratio (−0.72 95% CI−1.40, −0.05, I2=50%). In a subgroup analysis, low- and moderate-intensity IMT treatment was associated with a reduction of the heart rate (HR) (−7.59 95% CI −13.96, −1.22 bpm, I2=0%) and diastolic blood pressure (DBP) (−8.29 [−11.64, −4.94 mmHg], I2=0%), respectively.
Conclusion: IMT is an effective treatment for inspiratory muscle weakness in several populations and could be considered as a complementary treatment to improve the cardiovascular system, mainly HR and DBP. Further research is required to better understand the above findings.
Keywords: breathing exercises, respiratory muscle training, cardiovascular system
Introduction
Inspiratory muscle weakness may induce several impairments in both healthy1,2 and athletic individuals.3,4 Similarly, studies have demonstrated that inspiratory muscle strength also has an important role in the pathophysiology of exercise limitation in several clinical conditions.5 More recently, studies have found that maximal inspiratory pressure (MIP) is strongly correlated with VO2peak in patients after acute myocardial infarction and heart failure,6 reinforcing the influence of the inspiratory muscles on functional capacity.
Furthermore, studies suggest that inspiratory muscle strength may influence central hemodynamic measurements at rest, including cardiac output, mean arterial pressure and vascular resistance in heart failure patients.7 In this sense, inspiratory muscle training (IMT) has been tested to evaluate its effect over the autonomic nervous activity and blood pressure control.8–10 Ferreira et al9 demonstrated a significant influence of IMT on 24-hrs ambulatory blood pressure monitoringby reducing systolic and diastolic blood pressure (SDP and DBP) 7.9 and 5.5 mmHg, respectively.
More recently, IMT has been evaluated as an adjunct therapy to improve autonomic modulation due to the recognized respiratory effects. According to several studies, IMT may reduce sympathetic activity9,11 through respiratory muscle metaboreflex attenuation,12 improving functional capacity and physical performance.12–15 Therefore, the purpose of this study was to systematically review the effects of the IMT on global cardiovascular function through autonomic function modulation of heart rate variability (HRV) and arterial blood pressure.
Methods
This systematic review with meta-analysis was conducted following the PRISMA Statement for Reporting Systematic Review Analysis.16
Criteria for considering studies for this review
Type of studies
Controlled clinical trial studies evaluating IMT effects on cardiovascular function were included in the systematic review.
Types of participants
The trials evaluating IMT effects on blood pressure and autonomic modulation, without population restriction. The eligibility criteria to select studies were: i) the primary objective was related to the effects of IMT on the cardiovascular autonomic nervous system, arterial blood pressure and heart rate (HR), and ii) randomized clinical trials. Exclusion criteria were non-randomized trials and articles addressing other breathing exercises modalities (yoga, slow and fast breathing, expiratory muscle training).
Types of intervention
We included studies examining a program of IMT (≥1 week treatment) offered as a sole intervention or as an adjuvant to another form of exercise. Interventions could be compared to either an inactive control (eg, no treatment, placebo, or sham NMES) or an active control such as an alternative form of exercise. A placebo intervention was defined as a treatment group in which an identical IMT, but without resistance or with minimum resistance. A control intervention was defined as either no treatment (non-active) or another treatment modality (active control) not including IMT protocol.
Types of outcome
The primary outcomes were HR (measured by beats per minute, bpm), SBP, DBP and mean blood pressure (measured by millimeters of mercury, mmHg) and HRVfrequency domain components (LF, HF, and LF/HF; measured in normalized units). Inspiratory muscle strength (MIP; measured by cmH2O).
Search method for identification of studies
The Cochrane Library (online version 2018), PUBMED (1962–2018), EMBASE (1980–2018) electronic databases were searched to identify eligible studies. Two reviewers analyzed the results independently (GRC and GCJ). Searches were limited to randomized, controlled trials (RCTs) and a filter was applied to limit the search to human trials. No language restrictions were included. A sensitive search strategy for identifying RCTs was employed [16]. Additional studies were identified from the reference lists of the retrieved studies.
Keywords employed during searches
(“Breathing Exercises“[Mesh] OR “Maximal Respiratory Pressures“[Mesh] OR “Respiratory Muscles“[Mesh] OR “Muscle Strength“[Mesh]) AND (“Blood Pressure“[Mesh] OR “Arterial Pressure“[Mesh] OR ”Baroreflex”[Mesh] OR ”Heart Rate”[Mesh] OR ”Blood Pressure Monitoring, Ambulatory” OR ”Autonomic Nervous System”[Mesh] OR ”Vascular Resistance”[Mesh] OR ”Sympathetic Nervous System”[Mesh]) AND ((Clinical Study[ptyp] OR Clinical Trial[ptyp] OR Clinical Trial, Phase I[ptyp] OR Clinical Trial, Phase II[ptyp] OR Clinical Trial, Phase III[ptyp] OR Clinical Trial, Phase IV[ptyp] OR Controlled Clinical Trial[ptyp] OR Pragmatic Clinical Trial[ptyp] OR Randomized Controlled Trial[ptyp] OR Research Support, American Recovery and Reinvestment Act[ptyp] OR Research Support, N I H, Extramural[ptyp] OR Research Support, N I H, Intramural[ptyp] OR Research Support, Non U S Gov’t[ptyp] OR Research Support, U S Gov’t, Non P H S[ptyp] OR Research Support, U S Gov’t, P H S[ptyp] OR Research Support, US Government[ptyp]) AND Humans[Mesh]
Data collection and analysis
Study selection
The articles retrieved during the searches were initially screened based on the title and abstract for the exclusion of clearly irrelevant studies. For selection, abstracts had to identify the study design, appropriate population and relevant components of the intervention, as described above. Full-text articles of all potentially relevant RCTs were obtained and assessed independently by two reviewers (GRC and GCJ) for eligibility based on the defined inclusion criteria.
Quality assessment
The risk of bias in the eligible RCTs was assessed by a single reviewer (FVSC) and verified by a second reviewer (GRC). The following aspects of methodological quality were assessed: concealment of the allocation, intention-to-treat analysis, outcome assessment blinding and description of losses and exclusions. Quality was also evaluated globally using the scale proposed by PEDro scale.17
Data extraction
Relevant data regarding inclusion criteria (study design, participants, duration, frequency, intensity, comparisons, and outcomes), the risk of bias (randomization, blinding, attrition, and control) and results were extracted. If the study had more than two groups, we included those that presented with the greater effect size. Data extraction was performed by a single reviewer (GRC) and checked by a second reviewer (GCJ). Disagreements were resolved by consensus. The agreement ratio before amending any discrepancies was assessed using the Kappa coefficient, which was higher than 0.90. Authors were contacted when necessary for clarifications or to obtain further outcome details.
Statistical analysis
The data were processed following the Cochrane Handbook for Systematic Reviews of Interventions. For continuous variables, net changes were compared (ie, IMT group vs control group) by the weighted mean difference (WMD) and 95% CI. The SD was calculated for each study based on the change score method. Heterogeneity among the studies was explored qualitatively by comparing the characteristics of the studies and quantitatively using the chi-squared test of heterogeneity and the I2 statistic. When appropriate, the results of the studies were combined for each outcome to determine the overall estimate of the treatment effect. The effect model for meta-analysis was elected based on qualitative and quantitative analyses as well as the analysis of publication bias. All analyses were conducted using Review Manager version 5.3.
Results
Identification and selection of studies
The initial search led to the identification of 975 studies, among which 855 were considered potentially relevant based on the title and abstract. Twenty-nine potentially relevant studies were retrieved for detailed analysis.8,11,18–34 Only 10 articles met the eligibility criteria.9,35–43 Figure 1 shows the flowchart of the study selection process. Excluded studies and the reasons for their exclusion are detailed in Table 1.
Table 1.
Study | Reason for exclusion |
---|---|
Souza et al18 | Non-randomized trial and |
Jones et al19 | Other breathing exercise |
Posser et al8 | Protocol study |
Drozdz et al20 | Other breathing exercise |
Gething et al21 | Comparison between intensities different |
Jaenisch et al30 | Animal study |
Laohachai et al23 | Non-randomized study and without control group |
Kaminski et al11 | Absence of baseline and post-intervention data |
Laoutaris et al24 | Non-randomized study and without control group |
Logtenberg et al25 | Other breathing exercise |
Mourya et al26 | Other breathing exercise |
Tong et al27 | Inspiratory muscle training plus functional exercise |
Passfield et al28 | Hyperpnea during respiratory muscle training and without outcomes |
Correa et al29 | Heart rate, systolic and diastolic blood pressure were not shown |
Jaenisch et al22 | Animal study |
Sangthong et al31 | Other breathing exercise |
Silva et al34 | Data without mean |
Vivodtzev et al32 | Mixed intervention |
Ditterline et al33 | Absence of baseline and post-intervention data |
Description of studies and participants
The 10 studies analyzed involved a total of 267 subjects. Descriptions of all studies are presented in Table 2.
Table 2.
Study | Description | IMT group description | Comparison group | ||||
---|---|---|---|---|---|---|---|
Study design | Population | n | n | Age (years) | n | Age (years) | |
Campos et al (2018)35 | RCT | Chronic kidney disease | 41 | 29 | 48.8±12.9 | 12 | 52.67±14.6 |
Rodrigues et al (2018)41 | RCT | Older healthy | 20 | 12 | 64±3.0 | 8 | 64±4.0 |
DeLucia et al (2018)37 | RCT | Healthy women | 28 | 12 | 21.2±5.5 | 13 | 19.6±6.1 |
Ferreira et al (2017)9 | RCT | Hypertensive | 13 | 6 | 61.8±4.0 | 7 | 52.1±8.8 |
Feriani et al (2017)43 | CT | Metabolic Syndrome | 28 | 16 | 69±4.0 | 12 | 68±3.0 |
Moreno et al (2017)40 | RCT | Chronic heart failure | 26 | 13 | 61±14 | 13 | 60±13.0 |
Vranish et al (2016)42 | RCT | Obstructive sleep apnea | 24 | 12 | 61±13.5 | 12 | 69.1±11,7 |
Mills et al (2015)39 | RCT | Older healthy | 34 | 17 | 69±3.0 | 17 | 68±3.0 |
Mello et al (2012)38 | RCT | Chronic heart failure | 28 | 15 | 54.3±7.7 | 13 | 53.3±7.2 |
Correa et al (2011)36 | RCT | Diabetes | 25 | 12 | 63±7.0 | 13 | 63±7.0 |
Note: Age expressed in mean ± SD.
Abbreviations: CT, clinical trial; RCT, randomized clinical trial; IMT, inspiratory muscle training.
Interventions characteristics
The most common IMT intensity was low-intensity. Six studies compared the effects of low-intensity IMT,9,35,36,38,40,43 two studies examined moderate intensity IMT39,41 and two studies examined high-intensity IMT.37,42 Four studies used a medium resistance spring load device (PowerBreathe Classic, PoweBreathe International Ltd., Warwickshire, England, UK) to produce IMT,39–42 five studies used another spring-loaded device (Threshold IMT, Philips, Rotterdam, Netherlands)9,36,38,39,43 and one used another form of IMT (Threshold PEP, Philips).35 The studies were quite heterogeneous, and Table 3 provides a summary of the interventions employed in the different studies.
Table 3.
Study | IMT group description | Comparison group | Score PEDro | |||||
---|---|---|---|---|---|---|---|---|
Intensity (MIP) | Frequency (day/week) | Duration (week) | Time | Intensity type | Training type | Description | ||
Campos et al (2018)34 | 15 cmH2O 20 cmH2O | 3 | 8 | 30 mins | Low | Resistor Threshold PEP | Control | 6/10 |
Rodrigues et al (2018)40 | 30% (1 week) 50% after | 2×day/5–7 days | 5 | 30 breaths | Moderate | Resistor PowerBreathe Classic | Control | 4/10 |
DeLucia et al (2018)36 | 75% | 5 | 6 | – | High | Resistor Pressure Transducer | Sham (15%PImax) | 7/10 |
Moreno et al (2017)39 | 30% | 6 | 8 | 30 mins | Low | Resistor Threshold IMT and Powerbreathe | Control | 5/10 |
Feriani et al (2017)42 | 30% | 3 sets | 1 | 15 mins | Low | Resistor Threshold IMT | Control | 5/10 |
Vranish et al (2016)41 | 75% | Twice/day | 6 | 30 breaths | High | Resistor PowerBreathe Classic | Sham (15% PImax) | 5/10 |
Mills et al (2015)38 | 50% | 7 | 8 | 30 breaths | Low | Resistor PowerBreathe Classic | Control | 5/10 |
Ferreira et al (2013)9 | 30% | 7 | 8 | 30 mins | Low | Resistor Threshold IMT | Control | 6/10 |
Mello et al (2012)37 | 30% | 3×day during 7 week | 12 | 10 mins | Low | Resistor Threshold IMT | Control | 4/10 |
Correa et al (2011)35 | 30% | 7 | 8 | 30 mins | Low | Resistor Threshold IMT | Control | 6/10 |
Abbreviations: PEP, positive expiratory pressure; IMT, inspiratory muscle training; MIP, maximal inspiratory pressure.
Quality of the studies
The methodological quality of the eligible RCTs is presented in Table 3. The quality of most studies was poor to good. According to PEDro scale, six studies reached 4 to 5 points and four studies 6 to 7 points.
Effect of IMT on inspiratory muscle strength
The most frequent training intensity used was 30% of the MIP defined as low-intensity and four studies used 50% of the MIP (moderate-high intensity).44Treatment duration ranged from 1 to 12 weeks. All protocols performed weekly readjustments of MIP (Table 3). The number of training sessions ranged from 2 to 7 sessions per week for 15–30 mins duration. Three studies were performed twice or more per day.38,41,42 Six studies set the workload at 30% MIP with a total of 113 subjects in the IMT and 89 in the control group, and 4 studies which set the workload ≥50% MIP with a total of 32 subjects in the IMT and 31 in the control group. Overall, IMT was associated with a significant improvement in MIP when data of all studies were pooled (10 studies, n=263 subjects, WMD=27.57 cmH2O, 95% CI 18.48–37.45 cmH2O, I2=64%) (Figure 2). From subgroup analysis, low-intensity and moderate-high intensity IMT protocols produced similar effects from both low and high intensity protocols (low intensity: 7 studies, n=202 subjects; WMD=28.42, 95% CI 12.37–44.46 cmH2O, I2=73%; moderate-high intensity, 3 studies, n=63 subjects; WMD=25.55, 95% CI 19.42–31.68 cmH2O, I2=73%).
Effect of IMT on hemodynamic measures
Heart rate
Overall, IMT did not influence HR when data of all studies were pooled (10 studies, n=152 subjects, WMD=−4.32 bpm, 95% CI −9.56 to 0.91 bpm, I2=0%) (Figure 3A). In a subgroup analysis, only low-intensity IMT studies were associated with a reduction of the resting HR (4 studies, n=108 subjects; WMD=−7.59 bpm, 95% CI −13.96 to −1.22 bpm, I2=0%).
Systolic blood pressure
IMT did not modify SBP in the overall analysis (05 studies, n=63, WMD=−8.13 mmHg, 95% CI −21.17 to 4.91 mmHg, I2=89%). Subgroup analysis also did not demonstrate effects either in low and moderate to high intensity protocols–low intensity (03 studies, n=71 subjects, WMD=−0.94 mmHg, 95% CI −10.53 to 8.66 mmHg, I2=0%) and moderate-high intensity (02 studies, n=44, WMD=−15.79 mmHg, 95% CI −33.77 to 2.19 mmHg, I2=89%) (Figure 3B).
Diastolic blood pressure
Overall, IMT was not associated with a significant reduction of the DBP when data of all studies were pooled (05 studies, n=119 subjects, WMD=−3.30 mmHg, 95% CI −9.63 to 3.04 mmHg, I2=76%) (Figure 3C). Subgroup analysis found no positive effect of low-intensity IMT on DBP (03 studies, n=75 subjects; WMD=2.12 mmHg, 95% CI −1.78 to 6.01 mmHg, I2=0%), but moderate-high intensity IMT was associated with a significant reduction in DBP (02 studies, n=44 subjects; WMD=−8.29 mmHg, 95% CI −11.64 to −4.94 mmHg, I2=0%).
Effect of IMT on heart rate variability measures
Low- and high-frequency component
Overall analyses found that IMT did not favorably modulate the low- and high-frequency HRV components (Figure 4A and B). Subgroup analysis also found that low- and moderate-high intensity IMT was not associated with modulation of the low- and high-frequency HRV components.
Low- to high-frequency ratio
IMT was found to produce a slight reduction of the low- to high-frequency ratio when data of all studies were pooled (06 studies, n=144 subjects, WMD=−0.72, 95% CI −1.40 to −0.05, I2=50%) (Figure 4C). From subgroup analysis, only one IMT study with moderate-high intensity produced a significant reduction in the low- to high-frequency ratio (01 study, n=19 subjects, WMD=−2.29, 95% CI −4.12 to −0.46, I2=not applicable).
Discussion
Despite the considerable heterogeneity of the IMT protocols which evaluated cardiovascular effects (I2>60%), the results reaffirmed in both general or subgroup analysis an important effect of IMT on MIP with an overall effect of 27.57 cmH2O (95% CI 18.48–37.45). Regarding the cardiovascular effect of the IMT, this review only found a small decrease in the low to high-frequency ratio following IMT treatment −0.72 (95% CI −1.40 to −0.05). Moreover, from subgroup analysis, low-intensity IMT protocols were associated with an important reduction of the rest HR −7.59 bpm (95% CI −13.96 to −1.22) while moderate-high intensity protocols demonstrate a significant reduction in DBP −8.29 mmHg (95% CI −11.64 to −4.94) and greater effect on the low- to high-frequency ratio compared to the overall analysis 2.29 (95% CI −4.12 to −0.46). The effect from IMT on SBP in both overall and subgroup analysis (low and moderate-high intensity protocol) was not significant.
Selected studies on this meta-analysis included several different populations, including cardiovascular conditions (6 studies), healthy older adults (2 studies), Chronic kidney disease. (1 study), and obstructive sleep apnea (1 study). Therefore, the results from its meta-analysis must be evaluated with caution. Most of the above mentioned pathophysiological conditions have been strongly associated with inspiratory muscle weakness (IMW). Patients with IMW are more susceptible to muscle fatigue and consequently to metabolite accumulation which activates unmyelinated type IV phrenic afferent fibers that increases sympathetic outflow reflex activity and produces a vasoconstrictor response in resting limbs which has been referred to as “inspiratory muscle metaboreflex overactivation."40
Cardiovascular effects of IMT have been associated with the respiratory maneuver performed during the training sessions which inflates the lungs near maximum respiratory capacity that may cause pulmonary parasympathetic stimulation, and consequently sympathetic activity reduction and an increase in blood flow to the limbs, resulting in a flush of metabolites and attenuation of vasoconstriction.43 Therefore, in patients with essential hypertension, blood pressure reduction has been associated with sympathetic activation reduction and parasympathetic increase.9 Moreover, IMT has been associated with reduction in respiratory muscle oxygen demand/delivery mismatch and consequently reduces respiratory fatigue in heart failure patients.40
Low versus moderate-high intensity IMT protocols appear to elicit differences in HR and DBP with low-intensity IMT protocols associated with a reduction in HR reduction, which might be related to the greater number of repeated respiratory maneuvers, not possible with moderate-high intensity IMT, that facilitated a reduction in sympathetic nervous system activity. Conversely, moderate-high intensity protocols are more likely to stimulate mechanoreceptors insofar as vascular occlusion as a result of muscle contraction which has been related to an increase in BP.45
Clinical implications
The studies included in this meta-analysis found that IMT increases MIP and has a modest effect in only one of the HRV outcomes. IMT also decreased HR and DBP, but only in low or moderate-high intensity protocols alone. Cardiovascular patients were the main population in this review (6/10 studies).
Limitations
This present systematic review and meta-analysis have limitations that warrant consideration. The major limitation is related to the limited number of publications eligible for consideration and poor to modest study quality. Another limitation regards the moderate to high degree of heterogeneity in the studies analyzed, which is likely related to the different patient populations and variable characteristics investigated in this small number of RCTs.
Conclusion
IMT is an effective treatment for inspiratory muscle weakness in several populations and according to this review might also be considered as a complementary treatment for cardiovascular modulation mainly for HR and DBP. Further studies are required to understand better the role of IMT as a component or alternative to regular exercise protocols.
Disclosure
The authors declare that there are no conflicts of interest in this work.
References
- 1.McConnell AK, Lomax M. The influence of inspiratory muscle work history and specific inspiratory muscle training upon human limb muscle fatigue. J Physiol. 2006;577(Pt 1):445–457. doi: 10.1113/jphysiol.2006.117762 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Romer LM, Lovering AT, Haverkamp HC, Pegelow DF, Dempsey JA. Effect of inspiratory muscle work on peripheral fatigue of locomotor muscles in healthy humans. J Physiol. 2006;571(Pt 2):425–439. doi: 10.1113/jphysiol.2005.099697 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Dempsey JA, Sheel AW, St Croix CM, Morgan BJ. Respiratory influences on sympathetic vasomotor outflow in humans. Respir Physiol Neurobiol. 2002;130(1):3–20. doi: 10.1016/S0034-5687(01)00327-9 [DOI] [PubMed] [Google Scholar]
- 4.Romer LM, Polkey MI. Exercise-induced respiratory muscle fatigue: implications for performance. J Appl Physiol (1985). 2008;104(3):879–888. [DOI] [PubMed] [Google Scholar]
- 5.Ribeiro JP, Chiappa GR, Callegaro CC. The contribution of inspiratory muscles function to exercise limitation in heart failure: pathophysiological mechanisms. Rev Bras Fisioter. 2012;16(4):261–267. doi: 10.1590/S1413-35552012005000034 [DOI] [PubMed] [Google Scholar]
- 6.Neves LM, Karsten M, Neves VR, Beltrame T, Borghi-Silva A, Catai AM. Relationship between inspiratory muscle capacity and peak exercise tolerance in patients post-myocardial infarction. Heart Lung. 2012;41(2):137–145. doi: 10.1016/j.hrtlng.2011.07.010 [DOI] [PubMed] [Google Scholar]
- 7.Filusch A, Ewert R, Altesellmeier M, et al. Respiratory muscle dysfunction in congestive heart failure–the role of pulmonary hypertension. Int J Cardiol. 2011;150(2):182–185. doi: 10.1016/j.ijcard.2010.04.006 [DOI] [PubMed] [Google Scholar]
- 8.Posser SR, Callegaro CC, Beltrami-Moreira M, Moreira LB. Effect of inspiratory muscle training with load compared with sham training on blood pressure in individuals with hypertension: study protocol of a double-blind randomized clinical trial. Trials. 2016;17:382. doi: 10.1186/s13063-016-1514-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Ferreira JB, Plentz RD, Stein C, Casali KR, Arena R, Lago PD. Inspiratory muscle training reduces blood pressure and sympathetic activity in hypertensive patients: a randomized controlled trial. Int J Cardiol. 2013;166(1):61–67. doi: 10.1016/j.ijcard.2011.09.069 [DOI] [PubMed] [Google Scholar]
- 10.Hunt BE, Fahy L, Farquhar WB, Taylor JA. Quantification of mechanical and neural components of vagal baroreflex in humans. Hypertension. 2001;37(6):1362–1368. doi: 10.1161/01.HYP.37.6.1362 [DOI] [PubMed] [Google Scholar]
- 11.Kaminski DM, Schaan BD, Da Silva AM, Soares PP, Lago PD. Inspiratory muscle training in patients with diabetic autonomic neuropathy: a randomized clinical trial. Clin Autonomic Res. 2015;25(4):263–266. doi: 10.1007/s10286-015-0319-5 [DOI] [PubMed] [Google Scholar]
- 12.Witt JD, Guenette JA, Rupert JL, McKenzie DC, Sheel AW. Inspiratory muscle training attenuates the human respiratory muscle metaboreflex. J Physiol. 2007;584(Pt 3):1019–1028. doi: 10.1113/jphysiol.2007.140855 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Dall‘Ago P, Chiappa GR, Guths H, Stein R, Ribeiro JP. Inspiratory muscle training in patients with heart failure and inspiratory muscle weakness: a randomized trial. J Am Coll Cardiol. 2006;47(4):757–763. doi: 10.1016/j.jacc.2005.09.052 [DOI] [PubMed] [Google Scholar]
- 14.HajGhanbari B, Yamabayashi C, Buna TR, et al. Effects of respiratory muscle training on performance in athletes: a systematic review with meta-analyses. J Strength Cond Res. 2013;27(6):1643–1663. doi: 10.1519/JSC.0b013e318269f73f [DOI] [PubMed] [Google Scholar]
- 15.de Abreu RM, Rehder-Santos P, Minatel V, Dos Santos GL, Catai AM. Effects of inspiratory muscle training on cardiovascular autonomic control: a systematic review. Auton Neurosci. 2017;208:29–35. doi: 10.1016/j.autneu.2017.09.002 [DOI] [PubMed] [Google Scholar]
- 16.Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. B MJ 2009;339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther. 2003;83(8):713–721. [PubMed] [Google Scholar]
- 18.Nobre E Souza MA, Lima MJ, Martins GB, et al. Inspiratory muscle training improves antireflux barrier in GERD patients. Am J Physiol Gastrointest Liver Physiol. 2013;305(11):G862–867. doi: 10.1152/ajpgi.00093.2013 [DOI] [PubMed] [Google Scholar]
- 19.Jones CU, Sangthong B, Pachirat O, Jones DA. Slow breathing training reduces resting blood pressure and the pressure responses to exercise. Physiological Res. 2015;64(5):673–682. [DOI] [PubMed] [Google Scholar]
- 20.Drozdz T, Bilo G, Debicka-Dabrowska D, et al. Blood pressure changes in patients with chronic heart failure undergoing slow breathing training. Blood Press. 2016;25(1):4–10. [DOI] [PubMed] [Google Scholar]
- 21.Gething AD, Passfield L, Davies B. The effects of different inspiratory muscle training intensities on exercising heart rate and perceived exertion. Eur J Appl Physiol. 2004;92(1–2):50–55. doi: 10.1007/s00421-004-1044-2 [DOI] [PubMed] [Google Scholar]
- 22.Jaenisch RB, Bertagnolli M, Borghi-Silva A, Arena R, Lago PD. Respiratory muscle training improves diaphragm citrate synthase activity and hemodynamic function in rats with heart failure. Braz J Cardiovasc Surg. 2017;32(2):104–110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Laohachai K, Winlaw D, Selvadurai H, et al. Inspiratory muscle training is associated with improved inspiratory muscle strength, resting cardiac output, and the ventilatory efficiency of exercise in patients with a fontan circulation. J Am Heart Assoc. 2017;6:8. doi: 10.1161/JAHA.117.005750 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Laoutaris ID, Dritsas A, Brown MD, et al. Effects of inspiratory muscle training on autonomic activity, endothelial vasodilator function, and N-terminal pro-brain natriuretic peptide levels in chronic heart failure. J Cardiopulm Rehabil Prev. 2008;28(2):99–106. doi: 10.1097/01.HCR.0000314203.09676.b9 [DOI] [PubMed] [Google Scholar]
- 25.Logtenberg SJ, Kleefstra N, Houweling ST, Groenier KH, Bilo HJ. Effect of device-guided breathing exercises on blood pressure in hypertensive patients with type 2 diabetes mellitus: a randomized controlled trial. J Hypertens. 2007;25(1):241–246. doi: 10.1097/HJH.0b013e32801040d5 [DOI] [PubMed] [Google Scholar]
- 26.Mourya M, Mahajan AS, Singh NP, Jain AK. Effect of slow- and fast-breathing exercises on autonomic functions in patients with essential hypertension. J Altern Complementary Med. 2009;15(7):711–717. doi: 10.1089/acm.2008.0609 [DOI] [PubMed] [Google Scholar]
- 27.Tong TK, McConnell AK, Lin H, Nie J, Zhang H, Wang J. “Functional” inspiratory and core muscle training enhances running performance and economy. J Strength Cond Res. 2016;30(10):2942–2951. doi: 10.1519/JSC.0000000000000656 [DOI] [PubMed] [Google Scholar]
- 28.Passfield L, Dobbins T, Myers S, Reilly M, Williams EM. Acute cardio-respiratory changes induced by hyperpnoea using a respiratory muscle trainer. Ergonomics. 2005;48(11–14):1423–1432. doi: 10.1080/00140130500101510 [DOI] [PubMed] [Google Scholar]
- 29.Correa AP, Antunes CF, Figueira FR, de Castro MA, Ribeiro JP, Schaan BD. Effect of acute inspiratory muscle exercise on blood flow of resting and exercising limbs and glucose levels in type 2 diabetes. PLoS One. 2015;10(3):e0121384. doi: 10.1371/journal.pone.0121384 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Jaenisch RB, Hentschke VS, Quagliotto E, et al. Respiratory muscle training improves hemodynamics, autonomic function, baroreceptor sensitivity, and respiratory mechanics in rats with heart failure. J Appl Physiol. 2011;111(6):1664–1670. doi: 10.1152/japplphysiol.01245.2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Sangthong B, Ubolsakka-Jones C, Pachirat O, Jones DA. Breathing training for older patients with controlled isolated systolic hypertension. Med Sci Sports Exerc. 2016;48(9):1641–1647. doi: 10.1249/MSS.0000000000000967 [DOI] [PubMed] [Google Scholar]
- 32.Vivodtzev I, Tamisier R, Croteau M, et al. Ventilatory support or respiratory muscle training as adjuncts to exercise in obese CPAP-treated patients with obstructive sleep apnoea: a randomised controlled trial. Thorax. 2018;73(7):634. doi: 10.1007/s00421-017-3750-6 [DOI] [PubMed] [Google Scholar]
- 33.Legg Ditterline BE, Aslan SC, Randall DC, Harkema SJ, Castillo C, Ovechkin AV. Effects of respiratory training on heart rate variability and baroreflex sensitivity in individuals with chronic spinal cord injury. Arch Phys Med Rehabil. 2018;99(3):423–432. doi: 10.1016/j.apmr.2017.06.033 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Dos Santos Silva M, Mostarda C, Lopes GS. Inspiratory muscle training reduces sympathetic modulation in elderly patients with insulin resistance. J Diabetes Sci Technol. 2013;7(6):1654–1656. doi: 10.1177/193229681300700630 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Campos NG, Marizeiro DF, Florencio ACL, et al. Effects of respiratory muscle training on endothelium and oxidative stress biomarkers in hemodialysis patients: a randomized clinical trial. Respir Med. 2018;134:103–109. doi: 10.1016/j.rmed.2017.12.005 [DOI] [PubMed] [Google Scholar]
- 36.Correa AP, Ribeiro JP, Balzan FM, Mundstock L, Ferlin EL, Moraes RS. Inspiratory muscle training in type 2 diabetes with inspiratory muscle weakness. Med Sci Sports Exerc. 2011;43(7):1135–1141. doi: 10.1249/MSS.0b013e3181edefaa [DOI] [PubMed] [Google Scholar]
- 37.DeLucia CM, De Asis RM, Bailey EF. Daily inspiratory muscle training lowers blood pressure and vascular resistance in healthy men and women. Exp Physiol. 2018;103(2):201–211. doi: 10.1113/eph.2018.103.issue-2 [DOI] [PubMed] [Google Scholar]
- 38.Mello PR, Guerra GM, Borile S, et al. Inspiratory muscle training reduces sympathetic nervous activity and improves inspiratory muscle weakness and quality of life in patients with chronic heart failure: a clinical trial. J Cardiopulm Rehabil Prev. 2012;32(5):255–261. doi: 10.1097/HCR.0b013e31825828da [DOI] [PubMed] [Google Scholar]
- 39.Mills DE, Johnson MA, Barnett YA, Smith WH, Sharpe GR. The effects of inspiratory muscle training in older adults. Med Sci Sports Exerc. 2015;47(4):691–697. doi: 10.1249/MSS.0000000000000651 [DOI] [PubMed] [Google Scholar]
- 40.Moreno AM, Toledo-Arruda AC, Lima JS, Duarte CS, Villacorta H, Nobrega ACL. Inspiratory muscle training improves intercostal and forearm muscle oxygenation in patients with chronic heart failure: evidence of the origin of the respiratory metaboreflex. J Card Fail. 2017;23(9):672–679. doi: 10.1016/j.cardfail.2017.05.010 [DOI] [PubMed] [Google Scholar]
- 41.Rodrigues GD, Gurgel JL, Goncalves TR, da Silva Soares PP. Inspiratory muscle training improves physical performance and cardiac autonomic modulation in older women. Eur J Appl Physiol. 2018;118(6):1143–1152. doi: 10.1007/s00421-017-3750-6 [DOI] [PubMed] [Google Scholar]
- 42.Vranish JR, Bailey EF. Inspiratory muscle training improves sleep and mitigates cardiovascular dysfunction in obstructive sleep apnea. Sleep. 2016;39(6):1179–1185. doi: 10.5665/sleep.5826 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Feriani DJ, Coelho HJJ, Scapini KB, et al. Effects of inspiratory muscle exercise in the pulmonary function, autonomic modulation, and hemodynamic variables in older women with metabolic syndrome. J Exerc Rehabil. 2017;13(2):218–226. doi: 10.12965/jer.1734896.448 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Romer LM, McConnell AK. Specificity and reversibility of inspiratory muscle training. Med Sci Sports Exerc. 2003;35(2):237–244. doi: 10.1249/01.MSS.0000048642.58419.1E [DOI] [PubMed] [Google Scholar]
- 45.Weippert M, Behrens M, Gonschorek R, Bruhn S, Behrens K. Muscular contraction mode differently affects autonomic control during heart rate matched exercise. Front Physiol. 2015;6:156. doi: 10.3389/fphys.2015.00098 [DOI] [PMC free article] [PubMed] [Google Scholar]